​

Vicore Pharma Holding AB (VCRE) Revenue & Revenue Breakdown


OverviewFinancialsChart

Vicore Pharma Holding AB Revenue Highlights


Latest Revenue (Y)

$3.82M

Latest Revenue (Q)

$228.25K

Vicore Pharma Holding AB Revenue by Period


Vicore Pharma Holding AB Revenue by Year

DateRevenueChange
2025-12-31$3.82M-

Vicore Pharma Holding AB generated $3.82M in revenue during NA 2025, up 0.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Vicore Pharma Holding AB Revenue by Quarter

DateRevenueChange
2026-06-30$228.25K-62.09%
2026-03-31$602.00K43.68%
2025-12-31$419.00K419.05%
2025-09-30$80.72K-

Vicore Pharma Holding AB generated $228.25K in revenue during Q2 2026, up -62.09% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Vicore Pharma Holding AB Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
LQDALiquidia$158.32M$171.68M
VCREVicore Pharma AB$3.82M$228.25K

VCRE Revenue FAQ


What is Vicore Pharma Holding AB’s yearly revenue?

Vicore Pharma Holding AB's yearly revenue for 2025 was $3.82M, representing an increase of 0% compared to 2024.

What is Vicore Pharma Holding AB’s quarterly revenue?

Vicore Pharma Holding AB's quarterly revenue for Q2 2026 was $228.25K, a -62.09% decrease from the previous quarter (Q1 2026). The company's quarterly revenue for Q1 2026 was $602K, a 43.68% increase from the previous quarter (Q4 2025). VCRE's quarterly revenue for Q4 2025 was $419K, a 419.05% increase from the previous quarter (Q3 2025).